Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparing the Effects of Hydroxychloroquine (HCQ) to Pioglitazone in Type 2 Diabetic Patients Failing Maximal Doses of Metformin Plus a Sulfonylurea

NCT02303405 is registered in ClinicalTrials.gov with Charles Drew University of Medicine and Science as lead sponsor.

NCT NCT02303405
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02303405 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparing the Effects of Hydroxychloroquine (HCQ) to Pioglitazone in Type 2 Diabetic Patients Failing Maximal Doses of Metformin Plus a Sulfonylurea
Lead sponsor
Charles Drew University of Medicine and Science
Phase
Phase 2
Overall status
Terminated
Start date
November 30, 2014
Completion date
November 30, 2017
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus type 2 with hyperglycemia